Aveanna Healthcare Holdings Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 8.03, above the company average. This is a clear sign of healthy business climate in the Healthcare Facilities industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Aveanna Healthcare Holdings Inc in Jul 04 2026 quarter, has decreased to 45 days, compared to 46 days, in the Apr 04 2026 quarter.

If we take a look into Healthcare sector 168 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1602, from overall ranking in the first quarter 2026 at 1945.

What is Receivable Turnover Ratio?
What is Aveanna Healthcare Holdings Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AVAH Receivables Turnover Ratio	(Jul 04 2026) II. Quarter	(Apr 04 2026) I. Quarter	(Jan 03 2026) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Receivable Change	6.63 %	12.84 %	18.16 %	17.85 %	15.87 %
Y / Y Revenue Change	13.73 %	15.86 %	27.43 %	22.18 %	16.75 %
Receivable Turnover Ratio (TTM)	8.03	7.91	7.87	7.71	7.63
AVAH's Total Ranking	# 1602	# 1945	# 1848	# 438	# 969
Accounts Receivable average collection period days	45	46	46	47	48
Seq. Receivable Change	1.37 %	6.17 %	0.17 %	-1.09 %	7.27 %
Seq. Revenue Change	3.48 %	-2.2 %	6.52 %	5.49 %	5.42 %

Receivable Turnover Company Ranking
Within:	No.
Healthcare Facilities Industry	# 23
Healthcare Sector	# 169
Overall Market	# 1602

Receivable Turnover Ratio Statistics
High	Average	Low
8.53	7.87	7.57
(Apr 03 2021)		(Oct 01 2022)

AVAH Company Profile • Back to AVAH Efficiency Comparisons • Compare AVAH Receivables Turnover Ratio to its Competitors

Financial Statements
Aveanna Healthcare Holdings Inc 's Accounts Receivable	$ 337 Millions	Visit AVAH's Balance sheet
Aveanna Healthcare Holdings Inc 's Sales TTM	$ 2,603 Millions	Visit AVAH's Income Statement
Sources of AVAH's Revenues		Visit AVAH's Sales by Geography

Other Accounts Receivable Turnover Ratios
Healthcare Facilities Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVAH's Receivable Turnover Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVAH's Growth Rates	AVAH's Roa	AVAH's Inventory Turnover Ratio	AVAH's Dividend Comparisons
AVAH's Profitability Ratios	AVAH's Roi	AVAH's Asset Turnover Ratio	AVAH's Dividend Growth
AVAH's Valuation Ratios	AVAH's Roe	AVAH's Financial Strength Ratios	AVAH's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jul 04 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jul 04 2026	Receivable at quarter ending Jul 04 2026
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Neuraxis Inc	18.95	$ 5.316 Millions	$ 0.281 Millions
China Pharma Holdings Inc	18.55	$ 3.914 Millions	$ 0.211 Millions
Bausch Health Companies Inc	18.42	$ 10,853.000 Millions	$ 589.250 Millions
Arvinas Inc	17.26	$ 316.700 Millions	$ 18.350 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Escalon Medical Corp	16.86	$ 12.736 Millions	$ 0.756 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Longeveron Inc	16.43	$ 1.187 Millions	$ 0.072 Millions
Bioage Labs Inc	15.82	$ 10.355 Millions	$ 0.655 Millions
Vaxart Inc	15.09	$ 243.064 Millions	$ 16.108 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
Skinhealth Systems Inc	14.42	$ 289.224 Millions	$ 20.051 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
10x Genomics Inc	13.90	$ 616.566 Millions	$ 44.342 Millions
Amneal Pharmaceuticals Inc	13.90	$ 3,117.474 Millions	$ 224.342 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Corcept Therapeutics Inc	13.54	$ 830.813 Millions	$ 61.352 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions
Precipio inc	13.25	$ 27.198 Millions	$ 2.052 Millions
Chemed Corporation	12.94	$ 2,595.001 Millions	$ 200.565 Millions
Qhslab Inc	12.77	$ 3.017 Millions	$ 0.236 Millions

Date modified: 2026-10-05T11:03:41+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.